2025 Annual Report of Independent Director (Wu Dailin)
I, Wu Dailin, as the independent director of Shanghai Kaixin Separation Technology Co., Ltd. (hereinafter referred to as "the Company"), have diligently performed my duties in accordance with the Company Law of the People's Republic of China, the Securities Law of the People's Republic of China, the Management Measures for Independent Directors of Listed Companies, the Listing Rules for the Growth Enterprise Market of the Shenzhen Stock Exchange, the Self-Regulatory Guidelines for Listed Companies No. 2 - Standardized Operations of Growth Enterprise Market Listed Companies, as well as the Company's Articles of Association and the Independent Director Work System. In 2025, I fully exercised my role as an independent director to safeguard the overall interests of the Company and the legitimate rights and interests of all shareholders, especially minority shareholders. The following is my report on the performance of independent director duties in 2025:
I. Basic Information of the Independent Director
Wu Dailin, male, born in 1967, holds a master's degree, is a Chinese national, and has no permanent residency abroad. He has previously served as the General Manager of the Investment Banking Department of Changjiang Securities Co., Ltd. in Wuhan, Deputy General Manager and Sponsor Representative of the Corporate Finance Department of Changjiang Paris BHF Securities Co., Ltd., Director and Vice President of Changjiang Securities Underwriting and Sponsorship Co., Ltd., Director, President, and Legal Representative of Changjiang Growth Capital Investment Co., Ltd., Member of the Party Committee and Vice President of Changjiang Securities Co., Ltd., Chairman and General Manager of Hubei New Energy Investment Management Co., Ltd., and Vice President of Jiangsu Private Investment Holdings Co., Ltd. He is currently the Managing Partner of Denning Private Equity Fund Management (Jiaxing) Partnership (Limited Partnership) and an independent director of the Company. During the reporting period, my position met the independence requirements stipulated in Article 6 of the Management Measures for Independent Directors of Listed Companies, and there were no circumstances affecting my independence.
II. Annual Performance of Duties
(A) Attendance at Board and Shareholder Meetings
In 2025, the Company held a total of 7 board meetings and 4 shareholder meetings. The operations of the board and shareholder meetings complied with legal procedures. With a prudent attitude, I voted in favor of all proposals submitted at each board meeting, with no instances of opposition or abstention. My attendance at board and shareholder meetings is as follows: